Oppenheimer Lowers Amrize (NYSE:AMRZ) Price Target to $55.00

Amrize (NYSE:AMRZ) had its price objective dropped by investment analysts at Oppenheimer from $62.00 to $55.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target would indicate a potential upside of 43.93% from the company’s previous close.

Several other equities research analysts have also recently issued reports on AMRZ. JPMorgan Chase & Co. cut shares of Amrize from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $57.00 to $52.00 in a research report on Wednesday, September 2nd. DA Davidson initiated coverage on Amrize in a research report on Monday, August 24th. They issued a “neutral” rating and a $50.00 target price on the stock. Zacks Research downgraded Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Stephens lowered their target price on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a research note on Wednesday, August 12th. Finally, Bank of America reissued an “underperform” rating and issued a $40.00 price target (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $54.88.

Amrize Price Performance

Shares of Amrize stock opened at $38.21 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The business has a 50 day simple moving average of $46.24 and a two-hundred day simple moving average of $51.73. The stock has a market capitalization of $21.13 billion, a P/E ratio of 17.61, a PEG ratio of 1.14 and a beta of 0.04. Amrize has a 12 month low of $38.17 and a 12 month high of $65.94.

Amrize (NYSE:AMRZ) last announced its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion for the quarter. As a group, analysts predict that Amrize will post 2.67 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jan Jenisch bought 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were purchased at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the purchase, the chief executive officer owned 519,000 shares of the company’s stock, valued at approximately $22,057,500. This represents a 0.78% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jacques Sanche purchased 4,150 shares of the stock in a transaction on Wednesday, August 26th. The shares were purchased at an average price of $45.02 per share, with a total value of $186,833.00. Following the acquisition, the director directly owned 9,766 shares in the company, valued at $439,665.32. This represents a 73.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders acquired 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Caldwell Sutter Capital Inc. increased its stake in Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock valued at $150,000 after purchasing an additional 275 shares during the period. Rothschild Investment LLC increased its stake in Amrize by 4.3% in the 4th quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock valued at $370,000 after buying an additional 280 shares during the period. Baldwin Investment Management LLC raised its holdings in Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock worth $486,000 after purchasing an additional 375 shares in the last quarter. Mengis Capital Management Inc. raised its stake in shares of Amrize by 8.5% during the 4th quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock worth $311,000 after buying an additional 450 shares in the last quarter. Finally, Norman Fields Gottscho Capital Management LLC raised its position in Amrize by 4.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock worth $614,000 after acquiring an additional 475 shares in the last quarter.

Amrize Company Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.